SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Matria Healthcare (MATR) -- Ignore unavailable to you. Want to Upgrade?


To: GREATMOOD who wrote (109)2/14/1998 8:37:00 PM
From: GREATMOOD  Read Replies (1) | Respond to of 220
 
Matria made a presentation at a Smith Barney conference on Friday.

I heard that it was well attended, and went extremely well, and judging by Friday's action, I would say that Matria was very well received by the Smith Barney group. It was nice to see powerful accumulation for a change. (Volume was almost 5 times greater than normal.) Matria is going to make 2 additional presentations in the next several weeks, and I hope the response will be similar to Friday's action.

As the story gets out, I think this will be a rewarding year for Matria's shareholders. The street is going to realize that Matria is a profitable, well managed, more diversified home healthcare company with several very promising ways to grow top line revenues.

Add to this the very good possibility of a share buy back program which would magnify earnings going forward, and the fact that they should have close to $1.00 per share in cash within a year. IMO this stock is extremely undervalued.

GM